Publications by authors named "Olivera M Andrejic"
Article Synopsis
- - Galectin-3 (Gal-3) is a biomarker linked to various diseases, particularly for assessing risks after acute myocardial infarction (AMI), which is a type of heart attack, helping doctors improve patient survival and quality of life.
- - In a study of 59 AMI patients, Gal-3 levels were measured within 24 hours of symptom onset, and results showed that higher levels of Gal-3 from the aortic root and femoral/radial artery predicted bad outcomes (major adverse cardiovascular events) at a six-month follow-up.
- - The research found that Gal-3 measurements from the aortic root were more effective in predicting risks than those from other sites, making it a crucial prognostic biomarker
: Given the fact that galectin-3 has a predictive significance on the development of myocardial dysfunction after acute myocardial infarction, the aim of our study was to examine potential factors that could be important for the dynamics of the concentration of this biomarker in the early postinfarction period. : This study included 89 patients with a diagnosis of stable angina pectoris (SAP) or the first non-ST elevation (NSTEMI) or ST-elevation (STEMI) myocardial infarction, who underwent percutaneous coronary intervention (PCI). The study group included 23 patients with the first NSTEMI and 42 patients with STEMI, while the control group consisted of 24 patients with SAP hospitalized for elective PCI without a previous MI.
View Article and Find Full Text PDFOur study investigates association between Galectin-3 levels and adverse left ventricular remodelling (LVR) at six months. Fifty-seven patients following first acute myocardial infarction (AMI) were enrolled in this study and blood samples collected on day 1 from the femoral vein and artery, the right atrium near the coronary sinus and the aortic root, and on day 30, from the cubital vein. Patients with LVESV ≥20% at six months, were included in the LVR group.
View Article and Find Full Text PDF